Ποια είναι η τιμή για Syngen Biotech Co.,Ltd. (8279)

Η τιμή για Syngen Biotech Co.,Ltd. (8279) είναι $2.70

Ποια είναι η κεφαλαιοποίηση αγοράς για Syngen Biotech Co.,Ltd. (8279)

Η κεφαλαιοποίηση αγοράς για Syngen Biotech Co.,Ltd. (8279) είναι $73.25M

Syngen Biotech Co.,Ltd. (8279) Τιμή και Κεφαλαιοποίηση Αγοράς

Established in 1988 and based in Tainan City, Taiwan, Syngen Biotech Co.,Ltd. operates globally, including in Taiwan and China, specializing in the research, development, production, and sale of a diverse array of products. Its core offerings include microbial pharmaceutical raw materials, biological pesticides, fertilizers, biochemical nutritional products, and preventive medicines. The company further manufactures dietary supplements and provides comprehensive contract manufacturing services for supplements, accommodating various formats such as sachets, liquids, tablets, cup package capsules, jellies, aluminum and glass bottles, and gummies. Syngen Biotech also develops and markets science-backed bioactive pharmaceutical ingredients (APIs) under proprietary brands including Oraltics, IMMUPHYLA, V3, ST4SanTex, GUARDSPO, benefiGANO, EXPUNERGY, and BIOJOVIAL. Additional services encompass private labelling, organic food OEM/ODM, explosion-proof extraction, brand agency, and wholesale distribution. Syngen Biotech caters to numerous industries, such as sport nutrition, beauty enhancement, baby and mother care, weight management, and digestion and detox. The company actively exports its products to approximately 20 countries worldwide.

Η τιμή για 8279	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$192,295 $73.25M	NVDA	$5.211T	+7,114,254.90%
$167,771 $73.25M	AAPL	$4.547T	+6,206,937.97%
$153,592 $73.25M	GOOG	$4.162T	+5,682,347.72%
$132,571 $73.25M	MSFT	$3.593T	+4,904,635.94%
$103,054 $73.25M	AMZN	$2.793T	+3,812,594.37%

Η τιμή για 8279

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$192,295 $73.25M